The battle against the most dangerous type of skin cancer has made a huge leap forward, and it could dramatically change the ...

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

In the phase 2b KEYNOTE-942 trial, researchers studied 157 patients with stage III or IV melanoma who had undergone surgery ...

Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting ...

Five-year KEYNOTE-942 data show a personalized cancer vaccine plus Keytruda reduced recurrence risk in patients with ...

Global pharmaceutical companies Moderna and MSD announced on the 1st (local time) the results of a joint Phase 2 clinical ...

A ‘TRANSFORMATIVE’ new vaccine that could prevent bowel and ovarian cancer has been developed by UK scientists. Scientists ...

Oxford and Moderna’s preventive mRNA cancer vaccine enters trials, targeting high-risk Lynch syndrome patients to train ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

Lynch syndrome is an inherited condition affecting 1 in 300 people that causes lifetime cancer risk of up to 80%[1]The ...

A vaccine and a drug that harness the immune system to attack cancer cells, has cut the risk of skin cancer recurrence and ...